The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

Thu, 24 Sep 2009 10:30:00 0500

-(Business Wire)-September 24, 2009 - MEDIA ADVISORY:

IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand

Thu, 24 Sep 2009 07:01:00 0500

NEW YORK-(Business Wire)-September 24, 2009 - The International AIDS Vaccine Initiative (IAVI) greeted with excitement today’s announcement by the U.S. Military HIV Research Program and the Thai Ministry of Public Health that, according to an initial analysis, a prime-boost combination of two...

Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities

Wed, 23 Sep 2009 15:37:00 0500

BOSTON-(Business Wire)-September 23, 2009 - The Blue Cross Blue Shield of Massachusetts Foundation has awarded $1.25 million in grants to 11 community health organizations around the Commonwealth to address health care disparities on the basis of race, ethnicity, immigration status, age, mental...

AHF’s Blair Underwood HIV/AIDS Clinic to Open in DC Thursday Sept. 24th

Wed, 23 Sep 2009 01:41:00 0500

WASHINGTON-(Business Wire)-September 23, 2009 - AIDS Healthcare Foundation...

ARISE Magazine is Proud to Announce Sponsorship Commitment to Alicia Keys’ 2009 Keep a Child Alive Black Ball

Tue, 22 Sep 2009 15:28:00 0500

NEW YORK-(Business Wire)-September 22, 2009 - Keep a Child Alive's (KCA) 2009 Black Ball, an annual benefit to raise funds dedicated to providing life-saving treatment and support to children and families affected by HIV/AIDS, is proud to announce ARISE Magazine as a confirmed sponsor...

Academy of Friends Selects Eleven Bay Area HIV/AIDS Organizations as 2010 Gala Beneficiaries

Tue, 22 Sep 2009 14:00:00 0500

SAN FRANCISCO-(Business Wire)-September 22, 2009 - Academy of Friends proudly announces its 2009-2010 fundraising for 11 Bay Area HIV/AIDS service organizations. Known for its annual Academy Awards^® Night Charity Gala and monthly social events, AOF raised more than $7.5 million...

AIDS Healthcare Foundation’s First ‘AHF Blair Underwood Healthcare Center’ to Open in DC

Mon, 21 Sep 2009 22:42:00 0500

WASHINGTON-(Business Wire)-September 21, 2009 - AIDS Healthcare Foundation...

Sloning Closes Growth Financing Round Led by LBBW Venture

Mon, 21 Sep 2009 13:41:00 0500

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

Mon, 21 Sep 2009 12:00:00 0500

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference...

NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies

Mon, 21 Sep 2009 11:00:00 0500

WEST HAVEN, Conn.-(Business Wire)-September 21, 2009 - NanoViricides, Inc. (OTC BB: NNVC.OB) (the...

MyInsuranceExpert Supports Local Aids Walk in Effort to Increase Healthy Living Awareness

Fri, 18 Sep 2009 20:48:00 0500

TROY, Mich.-(Business Wire)-September 18, 2009 - My Insurance Expert, one of the nation leading online services to compare and secure affordable health insurance, is supporting AIDS Walk Detroit 2009 with a corporate donation and encouraging employees and friends to participate in the annual...

Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program

Fri, 18 Sep 2009 15:08:00 0500

GREEN BAY, Wis.-(Business Wire)-September 18, 2009 - Integrative Therapeutics, Inc (ITI®), in collaboration with the American Association of Naturopathic Physicians (AANP), is seeking qualified residency sites for the fourth year of the ITI & AANP STAIR^SMResidency Scholarship...

The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

Fri, 18 Sep 2009 14:34:00 0500

-(Business Wire)-September 18, 2009 - MEDIA ADVISORY:

Hythiam Raises Approximately $7 Million in Registered Direct Offering

Thu, 17 Sep 2009 17:33:00 0500

LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering...

AHF Hosts Grand Opening of 1st Oakland “Out of the Closet”—the World’s Most Fabulous Thrift Store

Thu, 17 Sep 2009 15:00:00 0500

OAKLAND, Calif.-(Business Wire)-September 17, 2009 - AIDS Healthcare Foundation (AHF):

NNVC.OB) (the...

Merck's ISENTRESS® (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naïve Patients

Sun, 13 Sep 2009 18:15:00 0500

SAN FRANCISCO-(Business Wire)-September 13, 2009 - ISENTRESS^®, an integrase inhibitor from Merck & Co., Inc., was studied in comparison to efavirenz in maintaining viral load suppression to undetectable levels (less than 50 copies/mL) and at improving CD4 cell...

CA Legislature Passes Streamlined Rapid HIV Testing Bill; AHF Urges Schwarzenegger to Sign Common Sense Law

Sat, 12 Sep 2009 00:56:00 0500

SACRAMENTO, Calif.-(Business Wire)-September 12, 2009 - AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised the California Legislature for its passage of Assembly Bill 221, which cleared the Assembly on...

Research and Markets: Disease and Therapy Review: a Comprehensive Overview of HIV/AIDS and Related Conditions

Fri, 11 Sep 2009 15:00:00 0500

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets (

Warner Bros. Consumer Products Announces Highly Anticipated Online Auction for World-Renowned Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection in Celebration of the 70th Anniversary of The Wizard of Oz

Thu, 10 Sep 2009 14:00:00 0500

BURBANK, Calif.-(Business Wire)-September 10, 2009 - Warner Bros. Consumer Products today announced the opening of the highly anticipated online auction for The Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection, beginning September 10 at 10:00 a.m. EDT at...

HIV Screening Tests Proposed to Be Added to Medicare’s List of Covered Preventive Services

Wed, 09 Sep 2009 21:02:00 0500

WASHINGTON-(Business Wire)-September 9, 2009 - The Department of Health and Human Services (HHS) today announced a new proposal that would cover Human Immunodeficiency Virus (HIV) infection screening for Medicare beneficiaries who are at increased risk for the infection, including women who are...

St. Vincent’s, State Health Department Unveil Novel Technology to Fight Spread of HIV

Wed, 09 Sep 2009 16:44:00 0500

NEW YORK-(Business Wire)-September 9, 2009 - Saint Vincent Catholic Medical Centers and the New York State Department of Health (DOH) today unveiled a novel Web-based technology to rapidly instruct health care providers throughout New York State about HIV diagnosis and prevention.

Over One Third of All Oral and Throat Cancers Are Due to Sexual Practices

Wed, 09 Sep 2009 15:00:00 0500

BEVERLY HILLS, Calif.-(Business Wire)-September 9, 2009 - Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower...

Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers

Wed, 09 Sep 2009 12:00:00 0500

MOUNTAIN VIEW, Calif.-(Business Wire)-September 9, 2009 - Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009. Considering that fewer than 20 genomes have been...

Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs

Tue, 08 Sep 2009 14:00:00 0500

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Mohan Chellani, Ph.D., formerly a senior manager with Quest Diagnostics, as Vice President of Scientific Affairs at its Enzo Clinical Labs subsidiary. He will oversee all aspects of the...

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference

Tue, 08 Sep 2009 12:30:00 0500

BURLINGTON, N.C.-(Business Wire)-September 8, 2009 - Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare...

Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

Tue, 08 Sep 2009 12:00:00 0500

NEW YORK-(Business Wire)-September 8, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, and David...

IAVI: Two New Antibodies Found to Cripple HIV

Thu, 03 Sep 2009 18:07:00 0500

NEW YORK & LA JOLLA & SAN FRANCISCO, Calif. & SEATTLE-(Business Wire)-September 3, 2009 - Researchers at and associated with the International AIDS Vaccine Initiative (IAVI), at The Scripps Research Institute, and at the biotechnology companies Theraclone Sciences and Monogram...

Illumina to Present at Upcoming Investment Conferences in September

Thu, 03 Sep 2009 13:01:00 0500

SAN DIEGO-(Business Wire)-September 3, 2009 - Illumina, Inc. (NASDAQ:ILMN) today announced that the Company will webcast its presentations at three upcoming investment conferences.

Illumina will webcast its presentation at the Thomas Weisel Partners Healthcare Conference in...

AHF Challenges Merck’s “Criminal AIDS Drug Pricing” for Isentress

Thu, 03 Sep 2009 12:00:00 0500

WASHINGTON-(Business Wire)-September 3, 2009 - As part of its ongoing campaign to lower drug prices and increase access,

E-18 Corp. Announces Availability of SmallcapInsights.com Article

Tue, 01 Sep 2009 13:01:00 0500

MINNEAPOLIS-(Business Wire)-September 1, 2009 - E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a SmallcapInsights.com article by industry veteran, Dr...

WTN Services(R) and the Winetasting Network(R) Take Lead in Philanthropic Effort

Thu, 27 Aug 2009 13:04:00 0500

NAPA, Calif.-(Business Wire)-August 27, 2009 - WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community. WTN Services(R) and the...

AIDS Healthcare Foundation Mourns Kennedy as “Champion of People without a Voice”

Wed, 26 Aug 2009 18:41:00 0500

WASHINGTON-(Business Wire)-August 26, 2009 - AIDS Healthcare Foundation (AHF), the nation’s largest non-profit HIV/AIDS healthcare provider which now provides treatment and services for more than 100,000 individuals in 21 countries worldwide in the US, Africa, Latin America/Caribbean and...

Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain

Wed, 26 Aug 2009 13:00:00 0500

PLANTATION, Fla.-(Business Wire)-August 26, 2009 - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing...

Novelos Therapeutics Announces $9 Million Private Placement

Wed, 26 Aug 2009 13:00:00 0500

NEWTON, Mass.-(Business Wire)-August 26, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an...

AHF: L.A. County Says Impact of Thousands of Infections in Porn Industry, “Minimal”

Tue, 25 Aug 2009 13:30:00 0500

LOS ANGELES-(Business Wire)-August 25, 2009 - AIDS Healthcare Foundation:

Profectus BioSciences Enters into Research Collaboration Agreement with the PATH Malaria Vaccine Initiative (MVI)

Tue, 25 Aug 2009 12:30:00 0500

BALTIMORE-(Business Wire)-August 25, 2009 - Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the...

HHS Secretary Sebelius Announces Intent to Appoint Dr. Helene Gayle as Chair of the Presidential Advisory Council on HIV/AIDS at 2009 National HIV Prevention Conference

Mon, 24 Aug 2009 21:39:00 0500

WASHINGTON-(Business Wire)-August 24, 2009 - Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the...

BioAlliance Pharma: Loramyc® Obtains Marketing Authorization in Switzerland

Mon, 24 Aug 2009 16:00:00 0500

Regulatory News:

BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that Loramyc^® has obtained Marketing Authorization in Switzerland for the treatment of...

Novelos Therapeutics Completes Warrant Tender

Mon, 24 Aug 2009 12:30:00 0500

NEWTON, Mass.-(Business Wire)-August 24, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos issued approximately 2,100,000 shares of its Common Stock to...

Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study

Tue, 17 Feb 2009 14:00:00 0500

BOCA RATON, Fla.-(Business Wire)-February 17, 2009 - Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its wholly-owned drug discovery...

454 Sequencing Identifies Early Stage HIV Drug Resistance-- Low-level Mutations may have Significant Impact on Clinical Outcomes

Tue, 17 Feb 2009 13:00:00 0500

BRANFORD, Conn-(Business Wire)-February 17, 2009 - A research study published online this week in the Journal of Infectious Disease reports that HIV resistance mutations present in as little as 1% of the viral population have a significant impact on clinical outcomes. The paper outlines the...

FOX Rejects PG-rated AHF Condom Ad during Raunchy ‘Family Guy’

Fri, 13 Feb 2009 03:15:00 0500

LOS ANGELES-(Business Wire)-February 13, 2009 - AIDS Healthcare Foundation (AHF):

LabCorp is the First National Commercial Lab to Offer Roche’s COBAS® AmpliPrep/COBAS® TaqMan® HCV Test

Thu, 12 Feb 2009 21:15:00 0500

BURLINGTON, N.C.-(Business Wire)-February 12, 2009 - Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS...

AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+

Thu, 12 Feb 2009 01:22:00 0500

LOS ANGELES-(Business Wire)-February 12, 2009 - A groundbreaking global effort led by AIDS...

Panacos Announces Additional Personnel Departures

Wed, 11 Feb 2009 21:10:00 0500

WATERTOWN, Mass.-(Business Wire)-February 11, 2009 - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), today announced the Company’s Chief Medical Officer, Scott McCallister, and the Vice President of Manufacturing Operations, John Richards, will leave Panacos on February 13, 2009. These positions...

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

Wed, 11 Feb 2009 21:00:00 0500

NEWTON, Mass.-(Business Wire)-February 11, 2009 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, announced today that Novelos signed an exclusive collaboration agreement with Mundipharma...

OraSure Announces Fourth Quarter and Full Year 2008 Financial Results

Wed, 11 Feb 2009 21:00:00 0500

BETHLEHEM, Pa.-(Business Wire)-February 11, 2009 - OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in oral fluid diagnostics, today announced revenues of $71.1 million and $17.2 million for the year and quarter ended December 31, 2008, respectively. This compares to revenues of $82.7...

NERI to Launch First Multi-National Observational Registry for Men Diagnosed with Testosterone Deficiency

Wed, 11 Feb 2009 18:17:00 0500

WATERTOWN, Mass.-(Business Wire)-February 11, 2009 - New England Research Institutes, Inc. (NERI), is developing and launching a large, multi-national observational (non-intervention) registry for men with testosterone deficiency, a condition also known as hypogonadism (HG) or androgen...

BioAlliance Pharma: 2008 Consolidated Turnover: +134%

Tue, 10 Feb 2009 16:40:00 0500

Regulatory News:

BioAlliance Pharma SA (Euronext Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced a 2008 turnover of €8.2 million, strongly increased from €3.5...

AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+

Tue, 10 Feb 2009 15:27:00 0500

LOS ANGELES-(Business Wire)-February 10, 2009 - A groundbreaking global effort led by AIDS...

Research and Markets: Good Prospects of Finding a Cure for HIV/AIDS in The Next Decade Reveals Report

Tue, 10 Feb 2009 14:55:00 0500

DUBLIN, Ireland-(Business Wire)-February 10, 2009 - Research and Markets ( Switching from Lopinavir/Ritonavir-Based to ISENTRESS-Based Combination Antiretroviral Therapy Significantly Improved Total Cholesterol, Triglycerides...

Phase III Studies Showed ISENTRESS® in Combination Therapy Provided Significant Viral Load Reductions through 96 Weeks in Treatment-Experienced Patients with Triple-Class Resistant HIV

Mon, 09 Feb 2009 23:15:00 0500

MONTREAL-(Business Wire)-February 9, 2009 - In new subgroup analyses of a Phase III study (STARTMRK) that compared Merck & Co., Inc.'s integrase inhibitor ISENTRESS^® (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated...

Gilead Announces Data Demonstrating Pharmacokinetic Boosting Activity of GS 9350

Mon, 09 Feb 2009 17:00:00 0500

MONTREAL-(Business Wire)-February 9, 2009 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced preclinical data and results from two Phase I studies for GS 9350, an investigational compound being developed as a pharmacoenhancing agent (“booster”) to increase blood levels and allow...

Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System

Mon, 09 Feb 2009 16:00:00 0500

OAKLAND, Calif.-(Business Wire)-February 9, 2009 - Ramsell Public Health Rx, a pharmacy benefit manager and information management company, today announced the availability of the AIDS Drug Assistance Program (ADAP) Data Management System, a highly configurable, web-based system designed to...

Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI)

Fri, 06 Feb 2009 13:20:00 0500

Regulatory News:

BioAlliance Pharma SA (Paris:BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announces the presentation of its results on a new quinoline family acting as HIV integrase...

Health Management Associates, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call and Webcast

Fri, 06 Feb 2009 11:05:00 0500

NAPLES, Fla.-(Business Wire)-February 6, 2009 - Health Management Associates, Inc. (NYSE:HMA) announced today that on February 23, 2009 it will report results for its fourth quarter and year ended December 31, 2008.

HMA will issue a press release after the market closes on...

The Genome Center at Washington University Scales-Up on Illumina Sequencers

Fri, 06 Feb 2009 11:00:00 0500

SAN DIEGO-(Business Wire)-February 6, 2009 - Illumina, Inc. (NASDAQ:ILMN) announced today that it has reached an agreement in principle for the Genome Center at Washington University School of Medicine in St. Louis to acquire 21 genome analyzers over the next several months to support the...

Progen-Avexa Merger Notice of Meeting and Independent Expert Report

Thu, 05 Feb 2009 13:00:00 0500

BRISBANE, Australia-(Business Wire)-February 5, 2009 - The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) today released the Notice of Meeting regarding the Avexa merger and share buy back and confirmed their unanimous recommendation for the proposed merger...

Avexa Announces Release of the Independent Expert Report

Thu, 05 Feb 2009 13:00:00 0500

MELBOURNE, Australia-(Business Wire)-February 5, 2009 - Avexa Limited (ASX:AVX) today released the Independent Expert’s Report prepared by Lonergan Edwards & Associates Limited. The report was commissioned for the purposes of Avexa shareholders’ assessment of the proposed merger of...

March 15th: Actor, Activist Blair Underwood to Join Thousands for Florida AIDS Walk 2009

Thu, 05 Feb 2009 13:00:00 0500

FT. LAUDERDALE, Fla.-(Business Wire)-February 5, 2009 - AIDS Healthcare Foundation:

Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material

Wed, 04 Feb 2009 16:56:00 0500

ROCKVILLE, Md.-(Business Wire)-February 4, 2009 - Omnia Biologics, Inc. (Rockville, MD) and Sumagen Co., Ltd. (London, ON) today jointly announced the successful completion of cGMP manufacture of Sumagen’s HIV/AIDS vaccine for a Phase I clinical trial. Safe, effective vaccines for HIV...

MEDNAX, Inc. Acquires Neonatal Practice

Wed, 04 Feb 2009 12:00:00 0500

FORT LAUDERDALE, Fla.-(Business Wire)-February 4, 2009 - MEDNAX, Inc. (NYSE:MD) today announced that it has completed the acquisition of a neonatal group based in Arlington, Texas.

Arlington Neonatal Intensive Care, P.A., is a two-physician practice that staffs the Level III...

Aethlon Medical Provides Clinical Update at International Conference on Dialysis

Tue, 03 Feb 2009 14:50:00 0500

SAN DIEGO-(Business Wire)-February 3, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that its Chief Science Officer, Dr. Richard H. Tullis presented a clinical report on the Aethlon Hemopurifier® to Nephrologists attending the International Conference on Dialysis on January 29th...

Affymax to Present at BIO CEO and Investor Conference

Tue, 03 Feb 2009 13:00:00 0500

PALO ALTO, Calif.-(Business Wire)-February 3, 2009 - Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, president and chief executive officer, will present at the 11^th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 2:15 p.m. ET at the Waldorf...

AHF: Senate Democrats Allow HIV Testing To Be Stripped From Stimulus

Tue, 03 Feb 2009 02:23:00 0500

WASHINGTON-(Business Wire)-February 3, 2009 - AIDS Healthcare Foundation (AHF), the...

Gilead Announces Senior Management Promotion

Mon, 02 Feb 2009 19:00:00 0500

FOSTER CITY, Calif.-(Business Wire)-February 2, 2009 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced the promotion of Andrew Cheng, MD, PhD to the newly created role of Senior Vice President, Development Operations. In this role, Dr. Cheng will be responsible for Gilead’s biometrics...

Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery

Mon, 02 Feb 2009 13:04:00 0500

DRESDEN, Germany-(Business Wire)-February 2, 2009 - Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that it has signed a research agreement to support Boehringer Ingelheim in its ongoing efforts to discover novel therapeutic drug...

ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation

Fri, 30 Jan 2009 17:15:00 0500

CHELMSFORD, Mass.-(Business Wire)-January 30, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS) and Alsius Medical Corporation in the...

Progen-Avexa Merger Update

Fri, 30 Jan 2009 13:00:00 0500

BRISBANE, Australia-(Business Wire)-January 30, 2009 - The directors of Progen Pharmaceuticals Limited (“Progen”) (ASX:PGL) (NASDAQ:PGLA) confirm their unanimous recommendation for the proposed merger with Avexa Limited (“Avexa”) (ASX:AVX). The board believes that the current merger...

AHF Applauds Senator Harkin for Championing HIV Testing in Stimulus Bill

Fri, 30 Jan 2009 01:21:00 0500

WASHINGTON-(Business Wire)-January 30, 2009 - AIDS Healthcare Foundation (AHF), the...

AHF: Abbott Censors AIDS Activists on YouTube?

Thu, 29 Jan 2009 22:33:00 0500

LOS ANGELES-(Business Wire)-January 29, 2009 - A video parody criticizing Abbott Laboratories Inc. for its AIDS drug pricing mysteriously disappeared from YouTube today after 36 hours and 902 views. AIDS Healthcare Foundation (AHF...

Altarum Acquires KAI Research, Inc.

Tue, 27 Jan 2009 16:58:00 0500

ANN ARBOR, Mich.-(Business Wire)-January 27, 2009 - Altarum Institute President and CEO Lincoln Smith announced today that Altarum has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI will become a for-profit, wholly-owned subsidiary and will continue to operate from its...

Bill Gates Publishes First Annual Letter

Mon, 26 Jan 2009 20:06:00 0500

SEATTLE-(Business Wire)-January 26, 2009 - Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his first Annual Letter on the work of the foundation—a candid and personal appraisal of the foundation’s efforts to date that also identifies his priorities for the...

Aethlon Medical Completes First Medical Device Study to Treat HIV/AIDS

Mon, 26 Jan 2009 14:19:00 0500

SAN DIEGO-(Business Wire)-January 26, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has completed the “first-in-man” study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the study...

IAVI and Algonomics to Collaborate on HIV Protein Design Project

Mon, 26 Jan 2009 14:00:00 0500

GENT, Belgium & NEW YORK-(Business Wire)-January 26, 2009 - The International AIDS Vaccine Initiative (IAVI) and Algonomics today announced a collaboration to modify an HIV protein in order to improve immune responses elicited by HIV vaccine candidates that include the protein as an insert...

Obama Lifts Global Funding Ban, Unties Hands of HIV/AIDS Groups, Says AHF

Sat, 24 Jan 2009 02:08:00 0500

WASHINGTON-(Business Wire)-January 24, 2009 - AIDS Healthcare Foundation (AHF)

VIRxSYS to Present at Phacilitate Cell & Gene Therapy Forum

Thu, 22 Jan 2009 21:25:00 0500

-(Business Wire)-January 22, 2009 - VIRxSYS

Celera Corporation Fourth Quarter Calendar 2008 Results and Conference Call Scheduled for February 17, 2009

Thu, 22 Jan 2009 21:15:00 0500

ALAMEDA, Calif.-(Business Wire)-January 22, 2009 - Celera Corporation (NASDAQ:CRA) announced today that it will issue fourth quarter calendar 2008 financial results on Tuesday, February 17, 2009. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy...

Red Ribbon Charitable Foundation to Support AHF’s HIV/AIDS Services in Rural Florida

Thu, 22 Jan 2009 13:00:00 0500

FT. LAUDERDALE, Fla.-(Business Wire)-January 22, 2009 - AIDS Healthcare Foundation...

The Royal Government of Cambodia Awards the ‘Royal Order of Sahametrei’ to Dr. Chinkholal Thangsing

Thu, 22 Jan 2009 00:02:00 0500

PHNOM PENH, Cambodia-(Business Wire)-January 22, 2009 - The Royal Government of Cambodia has awarded its prestigious “Royal Order of Sahametrei” to Dr. Chinkholal Thangsing, Asia Pacific Bureau Chief of AIDS Healthcare Foundation. The ‘Royal Order of Sahametrei’ is...

Dr. Leslie Z. Benet, An Internationally Recognized Expert in Drug Development, Has Joined Advisors at Viral Genetics

Wed, 21 Jan 2009 14:00:00 0500

SAN MARINO, Calif.-(Business Wire)-January 21, 2009 - Dr. Leslie Z. Benet, an internationally recognized drug development expert and one of the most highly cited pharmacologists in the world, has joined the advisors of Viral Genetics.

CEO, Viral Genetics, Haig Keledjian said...

Panacos Announces Sale of Bevirimat

Wed, 21 Jan 2009 11:30:00 0500

WATERTOWN, Mass.-(Business Wire)-January 21, 2009 - Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Myriad Pharmaceuticals, Inc. has acquired Panacos' rights and assets with...

House Adopts AHF Stimulus Funding Proposal for HIV Testing and Prevention

Sat, 17 Jan 2009 01:52:00 0500

WASHINGTON-(Business Wire)-January 17, 2009 - AIDS Healthcare Foundation (AHF...

Aussie Jessie Sparks Becomes a MAC Girl

Fri, 16 Jan 2009 19:51:00 0500

LOS ANGELES-(Business Wire)-January 16, 2009 - Since winning a Hollywood Music Award for “Best Adult Contemporary Artist”, Melbourne Australia’s singer-songwriter Jessie Sparks’ (ViraCor Laboratories, the leader in molecular...

BioAlliance Pharma Publishes Its 2009 Financial Calendar

Thu, 15 Jan 2009 17:05:00 0500

PARIS-(Business Wire)-January 15, 2009 - Regulatory News:

BioAlliance Pharma SA (Paris:BIO) has announced its financial calendar for 2009, which notably includes the publication dates for its revenue statements and half-year & annual accounts, as well as the date of its...

Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program

Thu, 15 Jan 2009 16:00:00 0500

COLUMBIA, Md.-(Business Wire)-January 15, 2009 - Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced U.S. Food and Drug Administration (FDA) clearance to broaden its expanded access program (EAP) for Prochymal, now making the investigational stem cell product available to adults with...

Room & Board Announces Two-Year Grant of $50,000 and Employee Time to Chicago House

Thu, 15 Jan 2009 14:30:00 0500

MINNEAPOLIS-(Business Wire)-January 15, 2009 - Room & Board, the Minneapolis-based furniture retailer offering unique home furnishings that combine classic, simple design and exceptional quality, today announced a two-year gift totaling $50,000 and employee volunteer time to Chicago House...

Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product

Thu, 15 Jan 2009 14:00:00 0500

COLUMBIA, Md.-(Business Wire)-January 15, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced today that it has held a successful pre-Biologics License Application (pre-BLA) meeting for Prochymal used in the treatment of graft-versus-host disease (GvHD). A BLA is a comprehensive regulatory...

Aethlon Medical Nears Completion of First Medical Device Study to Treat HIV/AIDS

Thu, 15 Jan 2009 11:00:00 0500

SAN DIEGO-(Business Wire)-January 15, 2009 - Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it is nearing completion of the “first-in-man” study of a medical device to treat Human Immunodeficiency Virus (HIV), the disease that causes Acquired Immune Deficiency Syndrome (AIDS). In the...

Immuron's BioGard HIV Antibody Into A U.S. Clinical Trial

Thu, 15 Jan 2009 06:47:00 0500

SAN FRANCISCO & MELBOURNE, Australia-(Business Wire)-January 15, 2009 -

Company Receives Grant to Further Develop Disease-Fighting Technology

Fri, 09 Jan 2009 15:44:00 0500

WEST LAFAYETTE, Ind.-(Business Wire)-January 9, 2009 - Kylin Therapeutics announces plans to further develop a Purdue University technology that could allow physicians to target drug delivery for treatment of diseases ranging from AIDS to cancer.

The life sciences firm received a...

Osiris Therapeutics Receives $5 Million Milestone Payment

Thu, 08 Jan 2009 14:00:00 0500

COLUMBIA, Md.-(Business Wire)-January 8, 2009 - Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced...

Celera to Webcast Presentation at JPMorgan Healthcare Conference

Wed, 07 Jan 2009 21:15:00 0500

ALAMEDA, Calif.-(Business Wire)-January 7, 2009 - Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the 27^th JPMorgan Annual Healthcare Conference on Wednesday, January 14, 2009. The presentation is scheduled to begin at 3:00 p.m. PT (6:00 p.m...

LabCorp To Present at the Goldman Sachs Healthcare Conference – Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance

Tue, 06 Jan 2009 13:16:00 0500

BURLINGTON, N.C.-(Business Wire)-January 6, 2009 - Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Healthcare Conference in New York City, NY...

ZymoGenetics to Webcast Presentation at J.P. Morgan Healthcare Conference

Tue, 06 Jan 2009 11:00:00 0500

SEATTLE-(Business Wire)-January 6, 2009 - ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, will provide an update on company activities at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday...

Incyte to Present at the 27th Annual JPMorgan Healthcare Conference

Mon, 05 Jan 2009 21:10:00 0500

WILMINGTON, Del.-(Business Wire)-January 5, 2009 - Incyte Corporation (Nasdaq:INCY) announced today it will present at the 27^th Annual JPMorgan Healthcare Conference on Tuesday, January 13, 2009 at 3:30 p.m. (Pacific Time) / 6:30 p.m. (Eastern Time).

Paul Friedman...

OraSure Technologies to Participate at the Eleventh Annual Needham Growth Conference

Mon, 05 Jan 2009 16:31:00 0500

BETHLEHEM, Pa.-(Business Wire)-January 5, 2009 - OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and Chief Executive Officer, will speak to the investment community at the Eleventh Annual Needham Growth Conference in New York at approximately 10:30 am...

Avexa and Progen Merger Update

Mon, 05 Jan 2009 13:00:00 0500

MELBOURNE, Australia-(Business Wire)-January 5, 2009 - Biotechnology companies Avexa Limited (ASX:AVX) and Progen Pharmaceuticals Limited (ASX:PGL) (NASDAQ:PGLA) announced an update to shareholders regarding their proposed merger.

The companies will be hosting a series of...

"Homophobe" Rick Warren Seeks Redemption at AHF’s "Out of the Closet," Says AHF

Tue, 23 Dec 2008 22:27:00 0500

LOS ANGELES-(Business Wire)-December 23, 2008 - AIDS Healthcare Foundation:

WHAT:

Court Orders Schwarzenegger Administration to Enforce HIV/AIDS Law, Says AHF

Tue, 23 Dec 2008 18:23:00 0500

LOS ANGELES-(Business Wire)-December 23, 2008 - The Superior Court of California, County of Los Angeles has entered a judgment and will issue a writ ordering California’s Department of Health Care Services (DHCS) to implement a landmark 2002 law intended to extend Medi-Cal (Medicaid...

Napo Pharmaceuticals Announces Publication of Paper on Crofelemer for Indication of Irritable Bowel Syndrome

Tue, 23 Dec 2008 18:00:00 0500

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-December 23, 2008 - Napo Pharmaceuticals, Inc., (“Napo”) announces that a paper entitled “Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients” (D-IBS) has been published in the...

CytoDyn Launches Feasibility Study in China

Fri, 19 Dec 2008 14:00:00 0500

SANTA FE, N.M.-(Business Wire)-December 19, 2008 - After meeting with representatives of the Xishan Economic Development Zone in Albuquerque, New Mexico, CytoDyn, Inc. (Pink Sheets: CYDY) has committed to a feasibility study in the People’s Republic of China. Dr. Feng Zhou, a Company...

AIDS Nobel Laureate Joins Viral Genetics

Thu, 18 Dec 2008 15:00:00 0500

SAN MARINO, Calif.-(Business Wire)-December 18, 2008 - Luc Montagnier, co-winner of the 2008 Nobel Prize for Medicine and the co-discoverer of the HIV virus, has joined Viral Genetics (OTCBB: VRAL), a biotechnology company that discovers and develops immune-based therapies.

Ardea Biosciences Announces $30.6 Million Private Placement

Thu, 18 Dec 2008 13:30:00 0500

SAN DIEGO-(Business Wire)-December 18, 2008 - Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that it has entered into a securities purchase agreement with certain institutional investors to raise approximately $30.6 million from the private placement of 2,737,336 newly issued shares of...

Researchers Successfully Used the 454 Sequencing System for Sensitive Detection of HIV Tropism

Thu, 18 Dec 2008 13:00:00 0500

BRANFORD, Conn.-(Business Wire)-December 18, 2008 - 454 Life Sciences, a Roche company, announced today that a team of researchers from the BC Centre of Excellence in HIV/AIDS and the University of British Columbia, Canada have used the Genome Sequencer FLX system to monitor low frequency HIV...

Starbucks and (RED) Debut the (STARBUCKS)RED Card to Help Save Lives in Africa

Thu, 18 Dec 2008 13:00:00 0500

SEATTLE-(Business Wire)-December 18, 2008 - Starbucks Coffee Company (Nasdaq: SBUX) announced today that beginning January 3, customers will have the opportunity to make their purchase at Starbucks stores (RED) when they use the new (STARBUCKS)^REDCard, a stored...

What:

Digital50.com AIDS News RSS Feed

SeraCare Life Sciences Awarded Multiple Contracts from the CDC and NIH to Support HIV Research and the Accuracy of HIV Testing

ABL and Evivar Medical Enter into Agreements to Form a Global Strategic Partnership and IP Cross-Licensing for Disease Management and Personalized Healthcare of Hepatitis B and HIV Infections

Computable Genomix Announces Contest For Genomics Researchers

San Francisco, Sept. 30th: Grand Opening of New AHF “Magic Johnson” HIV/AIDS Clinic on Church St.

Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology

Calypte Biomedical Announces Changes to its Board of Directors

pSivida Corp. Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2009

Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV

The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand

Blue Cross Blue Shield of Massachusetts Foundation Awards $1.25 Million to 11 Organizations Working to Reduce Health Care Disparities

AHF’s Blair Underwood HIV/AIDS Clinic to Open in DC Thursday Sept. 24th

ARISE Magazine is Proud to Announce Sponsorship Commitment to Alicia Keys’ 2009 Keep a Child Alive Black Ball

Academy of Friends Selects Eleven Bay Area HIV/AIDS Organizations as 2010 Gala Beneficiaries

AIDS Healthcare Foundation’s First ‘AHF Blair Underwood Healthcare Center’ to Open in DC

Sloning Closes Growth Financing Round Led by LBBW Venture

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

NanoViricides, Inc. Signs a Master Service Agreement with Southern Research Institute for further Influenza and HIV Studies

MyInsuranceExpert Supports Local Aids Walk in Effort to Increase Healthy Living Awareness

Integrative Therapeutics, Inc. Seeking 2010 Residency Sites for STAIR Scholarship Program

The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

Hythiam Raises Approximately $7 Million in Registered Direct Offering

AHF Hosts Grand Opening of 1st Oakland “Out of the Closet”—the World’s Most Fabulous Thrift Store

Merck's ISENTRESS® (raltegravir) Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naïve Patients

CA Legislature Passes Streamlined Rapid HIV Testing Bill; AHF Urges Schwarzenegger to Sign Common Sense Law

Research and Markets: Disease and Therapy Review: a Comprehensive Overview of HIV/AIDS and Related Conditions

Warner Bros. Consumer Products Announces Highly Anticipated Online Auction for World-Renowned Ruby Slipper Collection and The Inspirations of Oz Fine Art Collection in Celebration of the 70th Anniversary of The Wizard of Oz

HIV Screening Tests Proposed to Be Added to Medicare’s List of Covered Preventive Services

St. Vincent’s, State Health Department Unveil Novel Technology to Fight Spread of HIV

Over One Third of All Oral and Throat Cancers Are Due to Sexual Practices

Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers

Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference

Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference

IAVI: Two New Antibodies Found to Cripple HIV

Illumina to Present at Upcoming Investment Conferences in September

AHF Challenges Merck’s “Criminal AIDS Drug Pricing” for Isentress

E-18 Corp. Announces Availability of SmallcapInsights.com Article

WTN Services(R) and the Winetasting Network(R) Take Lead in Philanthropic Effort

AIDS Healthcare Foundation Mourns Kennedy as “Champion of People without a Voice”

Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain

Novelos Therapeutics Announces $9 Million Private Placement

AHF: L.A. County Says Impact of Thousands of Infections in Porn Industry, “Minimal”

Profectus BioSciences Enters into Research Collaboration Agreement with the PATH Malaria Vaccine Initiative (MVI)

HHS Secretary Sebelius Announces Intent to Appoint Dr. Helene Gayle as Chair of the Presidential Advisory Council on HIV/AIDS at 2009 National HIV Prevention Conference

BioAlliance Pharma: Loramyc® Obtains Marketing Authorization in Switzerland

Novelos Therapeutics Completes Warrant Tender

Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study

454 Sequencing Identifies Early Stage HIV Drug Resistance-- Low-level Mutations may have Significant Impact on Clinical Outcomes

FOX Rejects PG-rated AHF Condom Ad during Raunchy ‘Family Guy’

LabCorp is the First National Commercial Lab to Offer Roche’s COBAS® AmpliPrep/COBAS® TaqMan® HCV Test

AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+

Panacos Announces Additional Personnel Departures

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

OraSure Announces Fourth Quarter and Full Year 2008 Financial Results

NERI to Launch First Multi-National Observational Registry for Men Diagnosed with Testosterone Deficiency

BioAlliance Pharma: 2008 Consolidated Turnover: +134%

AHF’s World AIDS Day Testing Campaign Tests 1.5M People; Finds 61,000 HIV+

Research and Markets: Good Prospects of Finding a Cure for HIV/AIDS in The Next Decade Reveals Report

Phase III Studies Showed ISENTRESS® in Combination Therapy Provided Significant Viral Load Reductions through 96 Weeks in Treatment-Experienced Patients with Triple-Class Resistant HIV

Gilead Announces Data Demonstrating Pharmacokinetic Boosting Activity of GS 9350

Ramsell Public Health Rx Unveils AIDS Drug Assistance Program (ADAP) Data Management System

Bioalliance Pharma Presents Results on a New Quinoline Family on HIV Integrase Inhibitors at the 16Th Conference on Retroviruses and Opportunistic Infections (CROI)

Health Management Associates, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call and Webcast

The Genome Center at Washington University Scales-Up on Illumina Sequencers

Progen-Avexa Merger Notice of Meeting and Independent Expert Report

Avexa Announces Release of the Independent Expert Report

March 15th: Actor, Activist Blair Underwood to Join Thousands for Florida AIDS Walk 2009

Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material

MEDNAX, Inc. Acquires Neonatal Practice

Aethlon Medical Provides Clinical Update at International Conference on Dialysis

Affymax to Present at BIO CEO and Investor Conference

AHF: Senate Democrats Allow HIV Testing To Be Stripped From Stimulus

Gilead Announces Senior Management Promotion

Cenix BioScience Signs Research Agreement with Boehringer Ingelheim for RNAi-Based Target Discovery

ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation

Progen-Avexa Merger Update

AHF Applauds Senator Harkin for Championing HIV Testing in Stimulus Bill

AHF: Abbott Censors AIDS Activists on YouTube?